Total Valuation
GB Sciences has a market cap or net worth of $122.12K. The enterprise value is $1.87M.
Market Cap$122.12K
Enterprise Value$1.87M
Share Statistics
GB Sciences has 407,071,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding407,071,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
GB Sciences’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 39.97%.
Return on Equity (ROE)0.26
Return on Assets (ROA)-13.17
Return on Invested Capital (ROIC)39.97%
Return on Capital Employed (ROCE)0.28
Revenue Per Employee0.00
Profits Per Employee-680.84K
Employee Count2
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of GB Sciences is ―. GB Sciences’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio-0.49
Price to Fair Value-0.49
Price to FCF-2.64
Price to Operating Cash Flow-0.12
PEG Ratio0.03
Income Statement
In the last 12 months, GB Sciences had revenue of 0.00 and earned -1.36M in profits. Earnings per share was 0.00.
Revenue0.00
Gross Profit-624.00
Operating Income-1.42M
Pretax Income-1.36M
Net Income-1.36M
EBITDA-1.42M
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -736.92K and capital expenditures 0.00, giving a free cash flow of -506.44K billion.
Operating Cash Flow-736.92K
Free Cash Flow-506.44K
Free Cash Flow per Share>-0.01
Dividends & Yields
GB Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-168.29
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
GB Sciences upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
GB Sciences as a current ratio of 0.02, with Debt / Equity ratio of -33.11%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.68
Net Debt to EBITDA-1.23
Interest Coverage Ratio-6.49
Taxes
In the past 12 months, GB Sciences has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
GB Sciences EV to EBITDA ratio is -3.05, with an EV/FCF ratio of -4.43.
EV to Sales0.00
EV to EBITDA-3.05
EV to Free Cash Flow-4.43
EV to Operating Cash Flow-4.43
Balance Sheet
GB Sciences has $3.02K in cash and marketable securities with $1.99M in debt, giving a net cash position of -$1.99M billion.
Cash & Marketable Securities$3.02K
Total Debt$1.99M
Net Cash-$1.99M
Net Cash Per Share>-$0.01
Tangible Book Value Per Share-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for GB Sciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―